| Antigen | 21-aa peptide from Human Glut-9 (protein accession #Q9NRM0, refs 1); Designation (GT91-P, control peptide) conjugated to KLH; Epitope location~ C-terminal, Cytoplasmic domain |
| Form | Antigen/blocking Peptide |
| Product Type | Peptide |
| SpCrossreactivity | Human GT91-P peptide sequence is has no significant sequence homology with other gluts. Antibody crossreactivity in various species is not established. Control peptide, because of its low mol. Wt (<3 kDa), is not suitable for Western. It should be used for ELISA or antibody blocking experiments (use 5-10 ug control peptide per 1 ug of aff pure IgG or 1 ul antiserum) to confirm antibody specificity. |
| SpeciesReactivity | Human |
| SugApplications | Control or blocking peptides are recommended for ELISA plate coating for direct ELISA testing of antibodies or competitive ELISA, and antibody blocking or neutralization. |